Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Smartphone-Guided exercise program ease the burden of atrial fibrillation?

NCT ID NCT05164718

Disease control Sponsor: Norwegian University of Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial investigates whether a one-year, app-supported home exercise program can improve quality of life and reduce the time spent in atrial fibrillation (AF) compared to usual care. Participants have paroxysmal or persistent AF, are in sinus rhythm at the start, and use a smartphone. The program follows general physical activity guidelines, with a focus on moderate to vigorous exercise. All participants receive a heart monitor to track AF episodes throughout the study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
supervised home-based exercise program
What this could lead to
If effective, this could provide clear exercise guidelines for atrial fibrillation patients, improving their quality of life and reducing symptoms.
What could go wrong
This is a behavioral intervention, so results depend on adherence. The trial is relatively small and may not show significant benefits over usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

300 people

The number who actually took part.

Started

Feb 2022

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 79 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed informed consent * Diagnosed with paroxysmal or persistent AF in hospital registries * In sinus rhythm at baseline screening * Report \<75 minutes per week of vigorous and/or \<150 minutes of moderate intensity exercise the last three months * Use a smartphone Exclusion Criteria: * Permanent AF or persistent AF with at least one continuous episode lasting ≥3 months the last year * AF as a complication of acute coronary syndromes, cardiothoracic surgery or infections * Planned ablation procedure next 12 months or ablated last 6 months without known recurrence * Unstable coronary heart disease * De-compensated heart failure * Left ventricular ejection fraction \<40% * At least moderate to severe mitral or aortic pathology, or aortic aneurysms clinically incompatible with safe exercise * Moderate to severe chronic obstructive pulmonary disease (GOLD group C+D) * Ongoing severe cancer or active cancer treatment * Pacemaker or ICD * Pregnancy * Alcohol or drug abuse * Cognitive or serious psychiatric disease that may impede protocol compliance * Physical impairments or diseases hindering exercise or making exercise contraindicated * Resident of nursing home or other institution * Participation in conflicting research studies (i.e. lifestyle interventions)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation

Contacts and locations

Locations

  • St Olavs Hospital

    Trondheim, Norway

  • University Hospital of North Norway

    Tromsø, Norway

  • Vestre Viken HF

    Drammen, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.